Montchanin Asset Management LLC Buys Shares of 3,591 Procter & Gamble Company (The) $PG

Montchanin Asset Management LLC purchased a new stake in shares of Procter & Gamble Company (The) (NYSE:PG) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 3,591 shares of the company’s stock, valued at approximately $519,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Procter & Gamble by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock valued at $34,030,358,000 after purchasing an additional 2,829,151 shares during the period. State Street Corp increased its position in shares of Procter & Gamble by 1.0% during the 4th quarter. State Street Corp now owns 101,618,926 shares of the company’s stock valued at $14,563,008,000 after purchasing an additional 984,102 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Procter & Gamble by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 62,647,882 shares of the company’s stock worth $8,962,689,000 after purchasing an additional 1,974,556 shares during the period. Norges Bank bought a new position in shares of Procter & Gamble in the 4th quarter worth approximately $4,664,783,000. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of Procter & Gamble by 3.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 29,612,826 shares of the company’s stock worth $4,243,815,000 after buying an additional 1,091,091 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Trading Up 0.5%

Shares of NYSE:PG opened at $144.62 on Friday. The stock has a 50 day moving average of $147.71 and a 200 day moving average of $148.92. The company has a market cap of $336.77 billion, a PE ratio of 21.85, a price-to-earnings-growth ratio of 7.20 and a beta of 0.39. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25. The company has a current ratio of 0.68, a quick ratio of 0.53 and a debt-to-equity ratio of 0.42.

Procter & Gamble (NYSE:PG) last released its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.25%. The company had revenue of $21.20 billion for the quarter, compared to analysts’ expectations of $21.38 billion. During the same quarter last year, the business earned $1.48 EPS. The firm’s revenue was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, equities research analysts expect that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Stockholders of record on Friday, July 24th will be given a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date is Friday, July 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.71%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PG. TD Cowen boosted their target price on shares of Procter & Gamble from $142.00 to $150.00 and gave the company a “hold” rating in a research report on Monday, April 27th. Morgan Stanley decreased their price target on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Raymond James Financial dropped their price target on shares of Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 14th. Bank of America cut their price objective on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research report on Friday, July 10th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $163.00 price objective on shares of Procter & Gamble in a research note on Monday, April 27th. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $161.52.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Citigroup maintained a Buy rating and set a $170 price target, implying substantial potential upside from recent levels, although the target was reduced from $181. Procter & Gamble Given New $170 Price Target at Citigroup
• Positive Sentiment: Brokerage coverage still leans constructive, with PG receiving an average “Moderate Buy” rating; Jefferies also retained its Buy rating despite trimming its target to $177. PG Average Rating of Moderate Buy
• Positive Sentiment: Management is emphasizing innovation, productivity improvements, e-commerce growth and market-share gains to support a consumer recovery. New product and marketing initiatives, including Downy’s premium fragrance campaign, could help reinforce brand strength. PG Q4 Earnings Call Highlights

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.